Login
From:
Neuromyelitis News
(Uncensored)
subscribe
Low Rituximab Dose Effective at Preventing Relapses in NMOSD: Analysis | Treatment Over 3 Weeks Also Found to Reduce Disability Progression | Neuromyelitis News
https://neuromyelitisnews.com/news/low-rituximab-dose-effective-preventing-relapses-nmosd/
links
backlinks
Tagged with:
meta-analysis
relapse prevention
disability progression
low dose rituximab
Three weeks of low-dose rituximab was found to prevent relapses and disability progression in NMOSD patients, without serious side effects.
Roast topics
Find topics
Find it!
